Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAston Martin Lagonda Regulatory News (AML)

Share Price Information for Aston Martin Lagonda (AML)

Share Price is delayed by 15 minutes
Get Live Data
41.12    -1.44 (-3.38%)
Bid:
41.06
Ask:
43.48
Spread: 2.42 (5.894%)
Market Cap: £416.42m
AML Live PriceLast checked at - London Stock Exchange

Intraday Aston Martin Lagonda Share Chart

Directorate Change

8 Oct 2019 07:00

RNS Number : 0612P
Aston Martin Lagonda Global Hld PLC
08 October 2019
 

8 October 2019

This announcement contains inside information

Aston Martin Lagonda Global Holdings plc (the "Company")

Board and Committee Changes

 

The Company announces the following Board and Committee changes, with immediate effect. These changes relate to the shareholder representative directors and reflect the commitments given by the Adeem/Primewagon controlling shareholder group and the Investindustrial controlling shareholder group in their respective Relationship Agreements with the Company.

 

·; Mr Najeeb Al Humaidhi, the Representative of the Adeem/Primewagon controlling shareholder group, has nominated Mr Amr AbouelSeoud and Mr Mahmoud Samy Mohamed Aly El Sayed as their two continuing Adeem/Primewagon Non-Executive Directors. Mr Mahmoud Samy Mohamed Aly El Sayed has been appointed as the Adeem/Primewagon representative director on the Nomination Committee.

 

·; As provided in the Relationship Agreements, Mr Peter Rogers and Mr Mahmoud Samy will now serve as observers on the Audit and Risk Committee with no voting rights. They will remain on the Board as Non-Executive Directors.

 

·; As provided in the Relationship Agreements, Mr Dante Razzano and Mr Amr AbouelSeoud will now serve as observers on the Remuneration Committee with no voting rights. They will remain on the Board as Non-Executive Directors.

 

Following the above changes, the Company is now compliant with the UK Corporate Governance Code in relation to the composition of its Audit and Risk and Remuneration Committees. To achieve Board Code compliance, we are in discussion with independent non-executive director candidates and expect to announce the outcome shortly.

The Company thanks Messrs. Najeeb Al Humaidhi and Saoud Al Humaidhi for their service as directors in its first year since IPO and thanks them for their long-standing and continuing support as shareholders.

 

 

Enquiries:

 

Investors and Analysts

Charlotte Cowley, Director of Investor Relations +44 (0)7771 976764 charlotte.cowley@astonmartin.com

Media

Kevin Watters, Director of Communications +44 (0)7764 386683

kevin.watters@astonmartin.com

Grace Barnie, Corporate Communications Manager +44 (0)7880 903490 grace.barnie@astonmartin.com

 

Brunswick

Dan Roberts, Andrew Porter, Diana Vaughton +44 (0)20 7404 5959 astonmartin@brunswickgroup.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAUGGGWUUPBPUM
Date   Source Headline
4th Jun 20267:00 amRNSIssue of equity to satisfy share awards
15th May 20267:00 amRNSIssue of equity to satisfy employee share awards
6th May 202612:51 pmRNSVoting results of AGM 2026
29th Apr 20267:00 amRNSQ1 results for three months ended 31 March 2026
25th Mar 20269:53 amRNSAnnual Financial Report
9th Mar 202612:12 pmRNSResult of Meeting
25th Feb 20267:00 amRNSPreliminary Results FY2025
20th Feb 20267:00 amRNSNotice of GM and FY 2025 Trading Update
29th Oct 20257:00 amRNSQ3 results for the quarter ended 30 September 2025
6th Oct 20257:00 amRNSQ3 2025 Trading Update and revised outlook
10th Sep 202511:33 amRNSDirector/PDMR Shareholding
5th Sep 20257:00 amRNSIssue of equity to satisfy employee share awards
30th Jul 20257:00 amRNSInterim results
28th Jul 20254:33 pmRNSDirectorate Change
27th May 202510:13 amRNSDirector/PDMR Shareholding
27th May 202510:12 amRNSDirector/PDMR Shareholding
15th May 202510:38 amRNSHolding(s) in Company
13th May 20255:26 pmRNSHolding(s) in Company
13th May 202510:33 amRNSDirector/PDMR Shareholding
13th May 202510:31 amRNSDirector/PDMR Shareholding
13th May 202510:26 amRNSDirector/PDMR Shareholding
12th May 20255:53 pmRNSHolding(s) in Company
12th May 20251:13 pmRNSHolding(s) in Company
12th May 202512:52 pmRNSHolding(s) in Company
7th May 20252:45 pmRNSDirector/PDMR Shareholding
7th May 20251:15 pmRNSResult of General Meeting and issue of equity
7th May 20251:07 pmRNSVoting Result of AGM
30th Apr 20257:00 amRNS1st Quarter Results
17th Apr 20258:57 amRNSNotice of General Meeting
16th Apr 20253:20 pmRNSDirector Declaration
31st Mar 20255:11 pmRNSStatement regarding media comments
31st Mar 20257:00 amRNSProposed investment by Yew Tree Consortium
26th Mar 20259:24 amRNSAnnual Financial Report
26th Feb 20257:00 amRNSPreliminary results year ended 31 December 2024
25th Feb 202510:00 amRNSIndependent Non-executive Director appointment
7th Feb 20255:29 pmRNSHolding(s) in Company
13th Dec 20249:00 amRNSDirectorate Change
4th Dec 20244:00 pmRNSHolding(s) in Company
29th Nov 20244:15 pmRNSHolding(s) in Company
29th Nov 20241:01 pmRNSHolding(s) in Company
29th Nov 202412:46 pmRNSDirector/PDMR Shareholding Replacement
29th Nov 202412:18 pmRNSDirector/PDMR Shareholding
29th Nov 202412:17 pmRNSDirector/PDMR Shareholding
29th Nov 202412:11 pmRNSDirector/PDMR Shareholding
27th Nov 20247:00 amRNSResult of Equity Issue
26th Nov 20245:06 pmRNSIssue of Equity
26th Nov 20244:58 pmRNSIssue of Equity
6th Nov 202410:37 amRNSDirector/PDMR Shareholding
30th Oct 20247:00 amRNS3rd Quarter Results
30th Sep 20247:00 amRNSTrading Update and adjustment to FY 2024 guidance

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.